Edit |   |
---|---|
Antigenic Specificity | ITGAL & CD11a & CD18, Human (Rovelizumab biosimilar) |
Clone | Rovelizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock. |
Immunogen | n/a |
Other Names | Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab, Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody, Hu23F2G, Antibody Drug Analogues, Monoclonal Antibody, YR1202, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 339086-79-2 |
Catalog # | YR1202 |
Price | please inquire |
Order / More Info | ITGAL & CD11a & CD18, Human (Rovelizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |